CD4 and viral infectious disease: The magnitude of the CD4-CTL response has been associated with better clinical outcomes in both acute and chronic viral infections and antitumor immune responses, although a few reports suggest their protumoral roles and potential pathogenic role in SARS-CoV2 (13–15).